Standardization of an in vitro assay matrix to assess cytotoxicity of organic nanocarriers: a pilot interlaboratory comparison

Nanotechnologies such as nanoparticles are established components of new medical devices and pharmaceuticals. The use and distribution of these materials increases the requirement for standardized evaluation of possible adverse effects, starting with a general cytotoxicity screening. The Horizon 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Eder, Kai Moritz, Marzi, Anne, Wågbø, Ane Marit, Vermeulen, Jolanda P., de la Fonteyne-Blankestijn, Liset J. J., Rösslein, Matthias, Ossig, Rainer, Klinkenberg, Geir, Vandebriel, Rob J., Schnekenburger, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360155/
https://www.ncbi.nlm.nih.gov/pubmed/35794354
http://dx.doi.org/10.1007/s13346-022-01203-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360155/
https://www.ncbi.nlm.nih.gov/pubmed/35794354
http://dx.doi.org/10.1007/s13346-022-01203-9

Ejemplares similares